Method of determining a site of inflammation utilizing ELAM-1 ligands
Patent 5211937 Issued on May 18, 1993. Estimated Expiration Date: 
April 11, 2011. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
April 11, 2011. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent ReferencesArticle and method for measuring glucose level in body fluids Patent #: 4330299 InventorsAssigneeApplicationNo. 683458 filed on 04/11/1991US Classes:424/1.73, Attached to carbohydrate compound; derivative thereof (e.g., DNA, nucleotide, nucleoside, sugar, starch, tannin, saccharide, polysaccharide, cellulose, O-, N- and S-glycoside, vitamin B12)424/1.21Molecular bilayer structure (e.g., vesicle, liposome)ExaminersPrimary: Maples, John S.Attorney, Agent or FirmForeign Patent References
International ClassesA61K 049/02A61K 049/00 AbstractLigands in the form of N-acetyllactosamines which bind to endothelial leukocyte adhesion molecule-1 (ELAM-1) are disclosed. The ligand compounds can be formulated into pharmaceutical compositions and/or assay compositions used to alleviate inflammation and assay for the presence of (qualitative) and amount of (quantitative) ELAM-1 and thereby determine the presence, location and degree of inflammation.Other References
| |
